Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$63.15 - $72.88 $2,462 - $2,842
39 New
39 $2,000
Q3 2023

Oct 24, 2023

BUY
$73.94 - $80.67 $5,989 - $6,534
81 New
81 $6,000
Q3 2021

Nov 04, 2021

SELL
$67.69 - $73.03 $16,110 - $17,381
-238 Reduced 54.84%
196 $14,000
Q2 2021

Aug 04, 2021

BUY
$63.47 - $69.35 $126 - $138
2 Added 0.46%
434 $30,000
Q1 2021

Apr 29, 2021

BUY
$60.0 - $68.46 $180 - $205
3 Added 0.7%
432 $28,000
Q4 2020

Feb 11, 2021

BUY
$56.65 - $64.55 $113 - $129
2 Added 0.47%
429 $25,000
Q3 2020

Feb 11, 2021

BUY
$62.1 - $78.08 $186 - $234
3 Added 0.71%
427 $27,000
Q2 2020

Feb 11, 2021

BUY
$72.34 - $84.0 $144 - $168
2 Added 0.47%
424 $33,000
Q1 2020

Feb 11, 2021

BUY
$62.63 - $80.22 $125 - $160
2 Added 0.48%
422 $32,000
Q4 2019

Feb 11, 2021

BUY
$61.62 - $67.78 $25,880 - $28,467
420 New
420 $28,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Iag Wealth Partners, LLC Portfolio

Follow Iag Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iag Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iag Wealth Partners, LLC with notifications on news.